Biocompatibles wins IOM3 award for DC Bead technology

Polymer-based engineering solution deprives cancer cells of nutrients they need to survive

Biocompatibles UK, a medical technology company involved in drug device combination products, has won an award for the development of an innovative cancer product.

The Farnham, Surrey based firm received the Institute of Materials, Minerals and Mining (IOM3) award for Polymers in the Service of Mankind for its DC Bead technology from HRH The Prince Philip, in a ceremony at Buckingham Palace.

DC Bead is a polymer-based engineering solution that ultimately deprives cancer of the nutrients and oxygen that enable it to spread. It is used in a procedure called Transarterial Chemoembolisation (TACE), a minimally invasive medical procedure to restrict a tumour's blood supply. TACE has been used extensively to delay the progression of hepatocellular carcinoma (HCC), a type of liver cancer.

Biocompatibles UK’s main aim is to deliver products that are safe to use, economically viable, with clear clinical advantages. The firm's products use specialised polymer technology engineered to allow ease of delivery to blood vessels of tumours combined with controlled drug delivery capability. It is a pioneer in the use of drug-eluting beads to treat cancer.

Biocompatibles UK Ltd has been part of BTG International group company since 2008.

The Prince Philip award was established in 1973 and is awarded biennually (subject to sufficient merit).

You may also like

Regulatory

Takeda receives FDA clearance for HyHub devices to simplify HYQVIA administration

Needle-free infusion tools aim to improve in-home treatment for primary immunodeficiency and CIDP
Manufacturing

25 years of Guardtech: Isopod Manufacturing Director Michael Burton Q&A

One of the Group’s longest-serving superstars gives his thoughts on why the Guardtech Group are pushing the boundaries of small-scale cleanroom provision with their rapid-assembly pod systems
Manufacturing

Aenova expands Killorglin site with spray drying platform

New equipment to help overcome bioavailability hurdles and accelerate time-to-market
Manufacturing

Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition

Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong
Manufacturing

WLS introduces PR-12 and PR-24 plunger rod insertion and labelling systems

By improving reliability and streamlining production, the PR-12 and PR-24 help pharmaceutical manufacturers and contract packers protect product quality and reduce waste while maximising operational efficiencies
Manufacturing

Isopod Rapid Cleanrooms – the elite modular systems saving your host building from unwanted modifications

Suffolk-based cleanroom construction specialists the Guardtech Group have the perfect modular solution for clients who need to keep their host rooms intact
Pharmaceutical

Azelis strengthens its footprint in Italy with the acquisition of Azienda Chimica e Farmaceutica (‘ACEF’)

Azelis is pleased to announce that it has acquired 100% of the shares of Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharma industries in Italy
Subscribe now